Loading...

Spellberg Brad

Title(s)Associate Professor, Medicine
Phone(310) 781-3680
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Luna BM, Yan J, Reyna Z, Moon E, Nielsen TB, Reza H, Lu P, Bonomo R, Louie A, Drusano G, Bulitta J, She R, Spellberg B. Natural history of Acinetobacter baumannii infection in mice. PLoS One. 2019; 14(7):e0219824. PMID: 31318907.
      View in: PubMed
    2. Spellberg B, Rice LB. Duration of Antibiotic Therapy: Shorter Is Better. Ann Intern Med. 2019 Jul 09. PMID: 31284302.
      View in: PubMed
    3. Nielsen TB, Brass EP, Gilbert DN, Bartlett JG, Spellberg B. Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future? N Engl J Med. 2019 Jun 19. PMID: 31216396.
      View in: PubMed
    4. Chau E, Sarkarati M, Spellberg B. Adenosine Deaminase Diagnostic Testing in Pericardial Fluid. JAMA. 2019 Jun 14. PMID: 31199430.
      View in: PubMed
    5. Luna BM, Nielsen TB, Cheng B, Pantapalangkoor P, Yan J, Boyle-Vavra S, Bruhn KW, Montgomery C, Spellberg B, Daum R. Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition. PLoS One. 2019; 14(6):e0217439. PMID: 31181086.
      View in: PubMed
    6. Luna BM, Ershova K, Yan J, Ulhaq A, Nielsen TB, Hsieh S, Pantapalangkoor P, Vanscoy B, Ambrose P, Rudin S, Hujer K, Bonomo RA, Actis L, Skaar EP, Spellberg B. Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria. J Antimicrob Chemother. 2019 Jun 06. PMID: 31170282.
      View in: PubMed
    7. Spellberg B, Wong D, Holtom P. Reply to Author. Clin Infect Dis. 2019 May 09. PMID: 31069390.
      View in: PubMed
    8. Choi YJ, Kim S, Choi Y, Nielsen TB, Yan J, Lu A, Ruan J, Lee HR, Wu H, Spellberg B, Jung JU. Publisher Correction: SERPINB1-mediated checkpoint of inflammatory caspase activation. Nat Immunol. 2019 May; 20(5):664. PMID: 30846880.
      View in: PubMed
    9. Ambrose PG, VanScoy BD, Luna BM, Yan J, Ulhaq A, Nielsen TB, Rudin S, Hujer K, Bonomo RA, Actis L, Skaar E, Spellberg B. Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect. Antimicrob Agents Chemother. 2019 May; 63(5). PMID: 30782989.
      View in: PubMed
    10. Minejima E, Mai N, Bui N, Mert M, She RC, Nieberg P, Spellberg B, Wong-Beringer A. Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes. Clin Infect Dis. 2019 Apr 05. PMID: 30949675.
      View in: PubMed
    11. Choi YJ, Kim S, Choi Y, Nielsen TB, Yan J, Lu A, Ruan J, Lee HR, Wu H, Spellberg B, Jung JU. SERPINB1-mediated checkpoint of inflammatory caspase activation. Nat Immunol. 2019 03; 20(3):276-287. PMID: 30692621.
      View in: PubMed
    12. Wald-Dickler N, Spellberg B. Short Course Antibiotic Therapy-Replacing Constantine Units with "Shorter Is Better". Clin Infect Dis. 2019 Jan 07. PMID: 30615129.
      View in: PubMed
    13. Wong D, Holtom P, Spellberg B. Osteomyelitis Complicating Sacral Pressure Ulcers: Whether or Not to Treat With Antibiotic Therapy. Clin Infect Dis. 2019 Jan 07; 68(2):338-342. PMID: 29986022.
      View in: PubMed
    14. Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL, Schroeder DW, She R, Butler-Wu SM, Aguero-Rosenfeld ME, Zerr D, Fang FC, Ralston J, Riddell K, Scholes D, Weissman S, Parker K, Spellberg B, Johnson JR, Sokurenko EV. Rapid and Extensive Expansion in the United States of a New Multidrug-resistant Escherichia coli Clonal Group, Sequence Type 1193. Clin Infect Dis. 2019 Jan 07; 68(2):334-337. PMID: 29961843.
      View in: PubMed
    15. Wald-Dickler N, Holtom P, Spellberg B. Reply to Steigbigel and Steigbigel. Clin Infect Dis. 2019 Jan 07; 68(2):352-353. PMID: 30099501.
      View in: PubMed
    16. Yadav K, Masuda E, Minejima E, Spellberg B. Expected Practice as a Novel Antibiotic Stewardship Intervention. Open Forum Infect Dis. 2019 Jan; 6(1):ofy319. PMID: 30631789.
      View in: PubMed
    17. Spellberg B, Gaffin N. Procalcitonin-Guided Antibiotic Use. N Engl J Med. 2018 11 15; 379(20):1972-3. PMID: 30439593.
      View in: PubMed
    18. Nielsen TB, Yan J, Luna B, Spellberg B. Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia. J Vis Exp. 2018 06 28; (136). PMID: 30010650.
      View in: PubMed
    19. Coffey C, Cho ES, Wei E, Luu A, Ho M, Amaya R, Pecson M, Dalton FV, Kahaku D, Spellberg B, Sener SF. Lean methods to improve operating room elective first case on-time starts in a large, urban, safety net medical center. Am J Surg. 2018 Aug; 216(2):194-201. PMID: 29803501.
      View in: PubMed
    20. Wald-Dickler N, Holtom P, Spellberg B. Busting the Myth of "Static vs Cidal": A Systemic Literature Review. Clin Infect Dis. 2018 04 17; 66(9):1470-1474. PMID: 29293890.
      View in: PubMed
    21. Yen C, Holtom P, Butler-Wu SM, Wald-Dickler N, Shulman I, Spellberg B. Reducing Clostridium difficile Colitis Rates Via Cost-Saving Diagnostic Stewardship. Infect Control Hosp Epidemiol. 2018 06; 39(6):734-736. PMID: 29611494.
      View in: PubMed
    22. Spellberg B. The Maturing Antibiotic Mantra: "Shorter Is Still Better". J Hosp Med. 2018 05 01; 13(5):361.362. PMID: 29370317.
      View in: PubMed
    23. Coffey CE, Carter V, Wei E, Hutcheon D, Gruen JP, Anonas-Ternate A, Sandoval R, Marquez A, Sarff L, Spellberg B. No More 'Code Black': Intervention to Improve Inpatient Flow at a Large Public Hospital. Am J Med. 2018 04; 131(4):371-376. PMID: 29175310.
      View in: PubMed
    24. Spellberg B. Preserving the Health of the Public and Our Specialty. Clin Infect Dis. 2017 10 16; 65(9):1597. PMID: 28679159.
      View in: PubMed
    25. Spellberg B. Mucormycosis pathogenesis: Beyond Rhizopus. Virulence. 2017 11 17; 8(8):1481-1482. PMID: 28806142.
      View in: PubMed
    26. Nielsen TB, Pantapalangkoor P, Yan J, Luna BM, Dekitani K, Bruhn K, Tan B, Junus J, Bonomo RA, Schmidt AM, Everson M, Duncanson F, Doherty TM, Lin L, Spellberg B. Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE. MBio. 2017 08 22; 8(4). PMID: 28830942.
      View in: PubMed
    27. Nielsen TB, Pantapalangkoor P, Luna BM, Bruhn KW, Yan J, Dekitani K, Hsieh S, Yeshoua B, Pascual B, Vinogradov E, Hujer KM, Domitrovic TN, Bonomo RA, Russo TA, Lesczcyniecka M, Schneider T, Spellberg B. Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis. J Infect Dis. 2017 08 15; 216(4):489-501. PMID: 28931235.
      View in: PubMed
    28. Thompson GR, Blair JE, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Lopez R, Heidari A, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B, Johnson R. Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis. Clin Infect Dis. 2017 Jul 15; 65(2):338-341. PMID: 28419259.
      View in: PubMed
    29. Spellberg B. Sacubitril-Valsartan in Heart Failure. Ann Intern Med. 2017 05 02; 166(9):680. PMID: 28460379.
      View in: PubMed
    30. Luna BM, Ulhaq A, Yan J, Pantapalangkoor P, Nielsen TB, Davies BW, Actis LA, Spellberg B. Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1. mSphere. 2017 Mar-Apr; 2(2). PMID: 28497114.
      View in: PubMed
    31. Cheng BL, Nielsen TB, Pantapalangkoor P, Zhao F, Lee JC, Montgomery CP, Luna B, Spellberg B, Daum RS. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection. Hum Vaccin Immunother. 2017 07 03; 13(7):1609-1614. PMID: 28422567.
      View in: PubMed
    32. Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, van Duin D, Kreiswirth BN, Chambers HF, Fowler VG, Jacobs MR, Pulse ME, Weiss WJ, Bonomo RA. Can Ceftazidime-Avibactam and Aztreonam Overcome ß-Lactam Resistance Conferred by Metallo-ß-Lactamases in Enterobacteriaceae? Antimicrob Agents Chemother. 2017 04; 61(4). PMID: 28167541.
      View in: PubMed
    33. Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev. 2017 01; 30(1):409-447. PMID: 27974412.
      View in: PubMed
    34. Spellberg B, Bartlett JG, Gilbert DN. How to Pitch an Antibiotic Stewardship Program to the Hospital C-Suite. Open Forum Infect Dis. 2016 Oct; 3(4):ofw210. PMID: 27844028.
      View in: PubMed
    35. Spellberg B, Bonomo RA. Editorial Commentary: Ceftazidime-Avibactam and Carbapenem-Resistant Enterobacteriaceae: "We're Gonna Need a Bigger Boat". Clin Infect Dis. 2016 12 15; 63(12):1619-1621. PMID: 27624957.
      View in: PubMed
    36. Wei EK, Sarff L, Spellberg B. Debunking the July Effect Myth. J Patient Saf. 2016 Sep 08. PMID: 27611769.
      View in: PubMed
    37. Spellberg B. The New Antibiotic Mantra-"Shorter Is Better". JAMA Intern Med. 2016 09 01; 176(9):1254-5. PMID: 27455385.
      View in: PubMed
    38. Spellberg B, Brass E. The VITAL study: case control studies are hypothesis-generating. Lancet Infect Dis. 2016 08; 16(8):886. PMID: 27477970.
      View in: PubMed
    39. Spellberg B. Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Abscess. N Engl J Med. 2016 07 21; 375(3):284. PMID: 27468070.
      View in: PubMed
    40. Wong D, Spellberg B. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae. Virulence. 2017 05 19; 8(4):383-390. PMID: 27187821.
      View in: PubMed
    41. Spellberg B, Srinivasan A, Chambers HF. New Societal Approaches to Empowering Antibiotic Stewardship. JAMA. 2016 Mar 22-29; 315(12):1229-30. PMID: 26914942.
      View in: PubMed
    42. Rojas LJ, Taracila MA, Papp-Wallace KM, Bethel CR, Caselli E, Romagnoli C, Winkler ML, Spellberg B, Prati F, Bonomo RA. Boronic Acid Transition State Inhibitors Active against KPC and Other Class A ß-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design. Antimicrob Agents Chemother. 2016 Jan 04; 60(3):1751-9. PMID: 26729496.
      View in: PubMed
    43. Bruhn KW, Dekitani K, Nielsen TB, Pantapalangkoor P, Spellberg B. Ly6G-mediated depletion of neutrophils is dependent on macrophages. Results Immunol. 2016; 6:5-7. PMID: 26870635.
      View in: PubMed
    44. Russo TA, Spellberg B, Johnson JR. Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections. J Infect Dis. 2016 Mar 15; 213(6):901-3. PMID: 26563238.
      View in: PubMed
    45. Nielsen TB, Bruhn KW, Pantapalangkoor P, Junus JL, Spellberg B. Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies. BMC Microbiol. 2015 Nov 02; 15:252. PMID: 26526621.
      View in: PubMed
    46. Spellberg B, Brass EP. Noninferiority Doesn't Mean Not Inferior. Clin Infect Dis. 2016 Feb 15; 62(4):525-6. PMID: 26486703.
      View in: PubMed
    47. Bruhn KW, Spellberg B. Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections. Curr Opin Microbiol. 2015 Oct; 27:57-61. PMID: 26261881.
      View in: PubMed
    48. Spellberg B, Bonomo RA. Combination Therapy for Extreme Drug-Resistant Acinetobacter baumannii: Ready for Prime Time? Crit Care Med. 2015 Jun; 43(6):1332-4. PMID: 25978159.
      View in: PubMed
    49. Spellberg B, Doi Y. The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought. J Infect Dis. 2015 Dec 15; 212(12):1853-5. PMID: 25969562.
      View in: PubMed
    50. Broglio KR, Daar ES, Quintana M, Yuan Y, Kalsekar A, Spellberg B, Lewis RJ, Akker Dv, Detry MA, Le T, Berry SM. A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens. J Comp Eff Res. 2015 Mar; 4(2):101-14. PMID: 25825840.
      View in: PubMed
    51. Fleischman RJ, Kaji AH, Diaz VM, McKenzie K, Soltero P, Van Natta TL, Spellberg B. A simple intervention to improve hospital flow from emergency department to inpatient units. JAMA Intern Med. 2015 Feb; 175(2):289-90. PMID: 25545454.
      View in: PubMed
    52. Spellberg B, Bartlett J, Wunderink R, Gilbert DN. Novel approaches are needed to develop tomorrow's antibacterial therapies. Am J Respir Crit Care Med. 2015 Jan 15; 191(2):135-40. PMID: 25590154.
      View in: PubMed
    53. Bruhn KW, Pantapalangkoor P, Nielsen T, Tan B, Junus J, Hujer KM, Wright MS, Bonomo RA, Adams MD, Chen W, Spellberg B. Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia. J Infect Dis. 2015 Apr 15; 211(8):1296-305. PMID: 25378635.
      View in: PubMed
    54. Spellberg B, Gilbert DN. The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clin Infect Dis. 2014 Sep 15; 59 Suppl 2:S71-5. PMID: 25151481.
      View in: PubMed
    55. Kim D, Spellberg B. Does real-time feedback to residents with or without attendings improve medical documentation? Hosp Pract (1995). 2014 Aug; 42(3):123-30. PMID: 25255414.
      View in: PubMed
    56. Park H, Solis NV, Louie JS, Spellberg B, Rodriguez N, Filler SG. Different tumor necrosis factor a antagonists have different effects on host susceptibility to disseminated and oropharyngeal candidiasis in mice. Virulence. 2014 Jul 01; 5(5):625-9. PMID: 25007095.
      View in: PubMed
    57. Spellberg B. The future of antibiotics. Crit Care. 2014 Jun 27; 18(3):228. PMID: 25043962.
      View in: PubMed
    58. Chang DW, Huynh R, Sandoval E, Han N, Coil CJ, Spellberg BJ. Volume of fluids administered during resuscitation for severe sepsis and septic shock and the development of the acute respiratory distress syndrome. J Crit Care. 2014 Dec; 29(6):1011-5. PMID: 25027612.
      View in: PubMed
    59. David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth JJ, Volinski J, Spellberg B. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. Clin Infect Dis. 2014 Sep 15; 59(6):798-807. PMID: 24879783.
      View in: PubMed
    60. Spellberg B. Community-acquired pneumonia. N Engl J Med. 2014 05 08; 370(19):1861-2. PMID: 24806182.
      View in: PubMed
    61. Spellberg B, Bonomo RA. The deadly impact of extreme drug resistance in Acinetobacter baumannii. Crit Care Med. 2014 May; 42(5):1289-91. PMID: 24736340.
      View in: PubMed
    62. Shimizu E, Glaspy K, Witt MD, Poon K, Black S, Schwartz S, Bholat T, Diaz N, Kuo A, Spellberg B. Readmissions at a public safety net hospital. PLoS One. 2014; 9(3):e91244. PMID: 24618829.
      View in: PubMed
    63. Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, Rodvold KA, Spellberg B, Fowler VG. Antibacterial resistance leadership group: open for business. Clin Infect Dis. 2014 Jun; 58(11):1571-6. PMID: 24610430.
      View in: PubMed
    64. Spellberg B. Antibiotic judo: working gently with prescriber psychology to overcome inappropriate use. JAMA Intern Med. 2014 Mar; 174(3):432-3. PMID: 24474306.
      View in: PubMed
    65. Lin L, Pantapalangkoor P, Tan B, Bruhn KW, Ho T, Nielsen T, Skaar EP, Zhang Y, Bai R, Wang A, Doherty TM, Spellberg B. Transferrin iron starvation therapy for lethal bacterial and fungal infections. J Infect Dis. 2014 Jul 15; 210(2):254-64. PMID: 24446527.
      View in: PubMed
    66. Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 12; 12(12):963. PMID: 24232373.
      View in: PubMed
    67. Mendez CM, Harrington DW, Christenson P, Spellberg B. Impact of hospital variables on case mix index as a marker of disease severity. Popul Health Manag. 2014 Feb; 17(1):28-34. PMID: 23965045.
      View in: PubMed
    68. Shlaes DM, Sahm D, Opiela C, Spellberg B. The FDA reboot of antibiotic development. Antimicrob Agents Chemother. 2013 Oct; 57(10):4605-7. PMID: 23896479.
      View in: PubMed
    69. Montgomery CP, Daniels MD, Zhao F, Spellberg B, Chong AS, Daum RS. Local inflammation exacerbates the severity of Staphylococcus aureus skin infection. PLoS One. 2013; 8(7):e69508. PMID: 23861974.
      View in: PubMed
    70. Spellberg B, Harrington D, Black S, Sue D, Stringer W, Witt M. Capturing the diagnosis: an internal medicine education program to improve documentation. Am J Med. 2013 Aug; 126(8):739-743.e1. PMID: 23791207.
      View in: PubMed
    71. Spellberg B. End points in trials of treatments for skin infections. JAMA. 2013 May 22; 309(20):2091-2. PMID: 23695471.
      View in: PubMed
    72. Thompson G, Wang S, Bercovitch R, Bolaris M, Van Den Akker D, Taylor S, Lopez R, Catanzaro A, Cadena J, Chin-Hong P, Spellberg B. Routine CSF analysis in coccidioidomycosis is not required. PLoS One. 2013; 8(5):e64249. PMID: 23717579.
      View in: PubMed
    73. Spellberg B, Sue D, Chang D, Witt M. Change in intern calls at night after a work hour restriction process change. JAMA Intern Med. 2013 Apr 22; 173(8):707-9; discussion 663. PMID: 23529748.
      View in: PubMed
    74. Spellberg B, Taylor-Blake B. On the exoneration of Dr. William H. Stewart: debunking an urban legend. Infect Dis Poverty. 2013 Feb 18; 2(1):3. PMID: 23849720.
      View in: PubMed
    75. Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin Infect Dis. 2013 May; 56(10):1445-50. PMID: 23403172.
      View in: PubMed
    76. Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med. 2013 Jan 24; 368(4):299-302. PMID: 23343059.
      View in: PubMed
    77. Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun. 2013 Mar; 81(3):915-22. PMID: 23297385.
      View in: PubMed
    78. Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, Bonomo RA, Spellberg B. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine. 2013 Jan 02; 31(2):313-8. PMID: 23153442.
      View in: PubMed
    79. Lin L, Tan B, Pantapalangkoor P, Ho T, Baquir B, Tomaras A, Montgomery JI, Reilly U, Barbacci EG, Hujer K, Bonomo RA, Fernandez L, Hancock RE, Adams MD, French SW, Buslon VS, Spellberg B. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. MBio. 2012; 3(5). PMID: 23033474.
      View in: PubMed
    80. Spellberg B, Lewis RJ, Sue D, Chavoshan B, Vintch J, Munekata M, Kim C, Lanks C, Witt MD, Stringer W, Harrington D. A controlled investigation of optimal internal medicine ward team structure at a teaching hospital. PLoS One. 2012; 7(4):e35576. PMID: 22532860.
      View in: PubMed
    81. Baquir B, Lemaire S, Van Bambeke F, Tulkens PM, Lin L, Spellberg B. Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin. Clin Infect Dis. 2012 Apr; 54 Suppl 3:S229-32. PMID: 22431853.
      View in: PubMed
    82. Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012 Aug; 50(6):611-8. PMID: 22435877.
      View in: PubMed
    83. Luo G, Spellberg B, Gebremariam T, Bolaris M, Lee H, Fu Y, French SW, Ibrahim AS. Diabetic murine models for Acinetobacter baumannii infection. J Antimicrob Chemother. 2012 Jun; 67(6):1439-45. PMID: 22389456.
      View in: PubMed
    84. Spellberg B. Gastrointestinal mucormycosis: an evolving disease. Gastroenterol Hepatol (N Y). 2012 Feb; 8(2):140-2. PMID: 22485085.
      View in: PubMed
    85. Lewis RE, Lortholary O, Spellberg B, Roilides E, Kontoyiannis DP, Walsh TJ. How does antifungal pharmacology differ for mucormycosis versus aspergillosis? Clin Infect Dis. 2012 Feb; 54 Suppl 1:S67-72. PMID: 22247448.
      View in: PubMed
    86. Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJ. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis. 2012 Feb; 54 Suppl 1:S73-8. PMID: 22247449.
      View in: PubMed
    87. Kontoyiannis DP, Lewis RE, Lortholary O, Lotholary O, Spellberg B, Petrikkos G, Roilides E, Roillides E, Ibrahim A, Walsh TJ. Future directions in mucormycosis research. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S79-85. PMID: 22247450.
      View in: PubMed
    88. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012 Feb; 54 Suppl 1:S16-22. PMID: 22247441.
      View in: PubMed
    89. Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS One. 2012; 7(1):e29446. PMID: 22253723.
      View in: PubMed
    90. Daum RS, Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis. 2012 Feb 15; 54(4):560-7. PMID: 22186773.
      View in: PubMed
    91. Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012 Feb 01; 54(3):393-407. PMID: 22157324.
      View in: PubMed
    92. Lin L, Ibrahim AS, Baquir B, Palosaari A, Spellberg B. Luminescent-activated transfected killer cells to monitor leukocyte trafficking during systemic bacterial and fungal infection. J Infect Dis. 2012 Jan 15; 205(2):337-47. PMID: 22124127.
      View in: PubMed
    93. Spellberg B, Daum R. Development of a vaccine against Staphylococcus aureus. Semin Immunopathol. 2012 Mar; 34(2):335-48. PMID: 22080194.
      View in: PubMed
    94. Spellberg B. Acute bacterial skin and skin structure infection trials: the bad is the enemy of the good. Clin Infect Dis. 2011 Dec; 53(12):1308-9; author reply 1309-10. PMID: 22028435.
      View in: PubMed
    95. Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012 Mar; 67(3):715-22. PMID: 21937481.
      View in: PubMed
    96. Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, Urban CM, Spellberg BJ, Rhee D, Halstead DC, Pasculle AW, Doi Y. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol. 2011 Nov; 49(11):3849-54. PMID: 21918019.
      View in: PubMed
    97. Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, Gerding D, Lynfield R, Reller LB, Rex J, Schwartz D, Septimus E, Tenover FC, Gilbert DN. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011 May; 52 Suppl 5:S397-428. PMID: 21474585.
      View in: PubMed
    98. Miller LG, McKinnell JA, Vollmer ME, Spellberg B. Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infect Control Hosp Epidemiol. 2011 Apr; 32(4):342-50. PMID: 21460485.
      View in: PubMed
    99. Spellberg B. The antibiotic crisis: can we reverse 65 years of failed stewardship? Arch Intern Med. 2011 Jun 27; 171(12):1080-1. PMID: 21357798.
      View in: PubMed
    100. Spellberg B, Boucher H, Bradley J, Das A, Talbot G. To treat or not to treat: adjunctive antibiotics for uncomplicated abscesses. Ann Emerg Med. 2011 Feb; 57(2):183-5. PMID: 21251530.
      View in: PubMed
    101. Ibrahim AS, Gebremariam T, Luo G, Fu Y, French SW, Edwards JE, Spellberg B. Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins. Antimicrob Agents Chemother. 2011 Apr; 55(4):1768-70. PMID: 21263057.
      View in: PubMed
    102. Spellberg B, Lewis RJ, Boucher HW, Brass EP. Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia. Clin Investig (Lond). 2011 Jan 01; 1(1):19-32. PMID: 21927712.
      View in: PubMed
    103. Spellberg B, Ibrahim AS. Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep. 2010 Nov; 12(6):423-9. PMID: 21308550.
      View in: PubMed
    104. Spellberg B. Skin and soft-tissue infections: modern evolution of an ancient problem. Clin Infect Dis. 2010 Oct 15; 51(8):904-6. PMID: 20839952.
      View in: PubMed
    105. Spellberg B, Daum R. A new view on development of a Staphylococcus aureus vaccine: insights from mice and men. Hum Vaccin. 2010 Oct; 6(10):857-9. PMID: 20930569.
      View in: PubMed
    106. Spellberg B, Talbot G. Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010 Aug 01; 51 Suppl 1:S150-70. PMID: 20597666.
      View in: PubMed
    107. Ibrahim AS, Gebremariam T, Lin L, Luo G, Husseiny MI, Skory CD, Fu Y, French SW, Edwards JE, Spellberg B. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol. 2010 Aug; 77(3):587-604. PMID: 20545847.
      View in: PubMed
    108. Lin L, Ibrahim AS, Baquir B, Fu Y, Applebaum D, Schwartz J, Wang A, Avanesian V, Spellberg B. Safety and efficacy of activated transfected killer cells for neutropenic fungal infections. J Infect Dis. 2010 Jun 01; 201(11):1708-17. PMID: 20397927.
      View in: PubMed
    109. Luo G, Ibrahim AS, Spellberg B, Nobile CJ, Mitchell AP, Fu Y. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis. 2010 Jun 01; 201(11):1718-28. PMID: 20415594.
      View in: PubMed
    110. Liu M, Spellberg B, Phan QT, Fu Y, Fu Y, Lee AS, Edwards JE, Filler SG, Ibrahim AS. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010 Jun; 120(6):1914-24. PMID: 20484814.
      View in: PubMed
    111. Quan C, Spellberg B. Mucormycosis, pseudallescheriasis, and other uncommon mold infections. Proc Am Thorac Soc. 2010 May; 7(3):210-5. PMID: 20463250.
      View in: PubMed
    112. Baquir B, Lin L, Ibrahim AS, Fu Y, Avanesian V, Tu A, Edwards J, Spellberg B. Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein. J Infect Dis. 2010 Feb 01; 201(3):473-7. PMID: 20039802.
      View in: PubMed
    113. Lin L, Ibrahim AS, Xu X, Farber JM, Avanesian V, Baquir B, Fu Y, French SW, Edwards JE, Spellberg B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009 Dec; 5(12):e1000703. PMID: 20041174.
      View in: PubMed
    114. Ibrahim AS, Gebremariam T, French SW, Edwards JE, Spellberg B. The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis. J Antimicrob Chemother. 2010 Feb; 65(2):289-92. PMID: 19942619.
      View in: PubMed
    115. Spellberg B, Talbot GH, Boucher HW, Bradley JS, Gilbert D, Scheld WM, Edwards J, Bartlett JG. Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis. 2009 Aug 01; 49(3):383-91. PMID: 19555285.
      View in: PubMed
    116. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009 Jun 15; 48(12):1743-51. PMID: 19435437.
      View in: PubMed
    117. Spellberg B, Andes D, Perez M, Anglim A, Bonilla H, Mathisen GE, Walsh TJ, Ibrahim AS. Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother. 2009 Jul; 53(7):3122-5. PMID: 19433555.
      View in: PubMed
    118. Lin L, Ibrahim AS, Baquir B, Avanesian V, Fu Y, Spellberg B. Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus. FEMS Immunol Med Microbiol. 2009 Apr; 55(3):293-5. PMID: 19159425.
      View in: PubMed
    119. Freifeld A, Proia L, Andes D, Baddour LM, Blair J, Spellberg B, Arnold S, Lentnek A, Wheat LJ. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother. 2009 Apr; 53(4):1648-51. PMID: 19139290.
      View in: PubMed
    120. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009 Jan 01; 48(1):1-12. PMID: 19035777.
      View in: PubMed
    121. Ibrahim AS, Edwards JE, Bryant R, Spellberg B. Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol. 2009; 47(6):592-600. PMID: 18798118.
      View in: PubMed
    122. Spellberg B, Talbot GH, Brass EP, Bradley JS, Boucher HW, Gilbert DN. Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clin Infect Dis. 2008 Dec 01; 47 Suppl 3:S249-65. PMID: 19018610.
      View in: PubMed
    123. Spellberg B, Fleming TR, Gilbert DN. Executive summary: workshop on issues in the design and conduct of clinical trials of antibacterial drugs in the treatment of community-acquired pneumonia. Clin Infect Dis. 2008 Dec 01; 47 Suppl 3:S105-7. PMID: 18986274.
      View in: PubMed
    124. Ibrahim AS, Spellberg B, Edwards J. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008 Dec; 21(6):620-5. PMID: 18978530.
      View in: PubMed
    125. Ibrahim AS, Gebremariam T, Schwartz JA, Edwards JE, Spellberg B. Posaconazole mono- or combination therapy for treatment of murine zygomycosis. Antimicrob Agents Chemother. 2009 Feb; 53(2):772-5. PMID: 18936190.
      View in: PubMed
    126. Ibrahim AS, Gebremariam T, Liu M, Chamilos G, Kontoyiannis D, Mink R, Kwon-Chung KJ, Fu Y, Skory CD, Edwards JE, Spellberg B. Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J Infect Dis. 2008 Oct 01; 198(7):1083-90. PMID: 18694335.
      View in: PubMed
    127. Reed C, Bryant R, Ibrahim AS, Edwards J, Filler SG, Goldberg R, Spellberg B. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008 Aug 01; 47(3):364-71. PMID: 18558882.
      View in: PubMed
    128. Spellberg B, Ibrahim AS, Yeaman MR, Lin L, Fu Y, Avanesian V, Bayer AS, Filler SG, Lipke P, Otoo H, Edwards JE. The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun. 2008 Oct; 76(10):4574-80. PMID: 18644876.
      View in: PubMed
    129. Spellberg B. Dr. William H. Stewart: mistaken or maligned? Clin Infect Dis. 2008 Jul 15; 47(2):294. PMID: 18564938.
      View in: PubMed
    130. Spellberg B, Ibrahim AS, Lin L, Avanesian V, Fu Y, Lipke P, Otoo H, Ho T, Edwards JE. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J Infect Dis. 2008 Apr 01; 197(7):967-71. PMID: 18419471.
      View in: PubMed
    131. Spellberg B. Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge. PLoS Pathog. 2008 Feb 08; 4(2):e38. PMID: 18282100.
      View in: PubMed
    132. Ibrahim AS, Gebremariam T, Husseiny MI, Stevens DA, Fu Y, Edwards JE, Spellberg B. Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Antimicrob Agents Chemother. 2008 Apr; 52(4):1573-6. PMID: 18227182.
      View in: PubMed
    133. Ibrahim AS, Gebremariam T, Fu Y, Edwards JE, Spellberg B. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob Agents Chemother. 2008 Apr; 52(4):1556-8. PMID: 18212099.
      View in: PubMed
    134. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008 Jan 15; 46(2):155-64. PMID: 18171244.
      View in: PubMed
    135. Lin L, Ibrahim AS, Avanesian V, Edwards JE, Fu Y, Baquir B, Taub R, Spellberg B. Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant. Clin Vaccine Immunol. 2008 Mar; 15(3):582-4. PMID: 18184821.
      View in: PubMed
    136. Fu Y, Luo G, Spellberg BJ, Edwards JE, Ibrahim AS. Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans. Eukaryot Cell. 2008 Mar; 7(3):483-92. PMID: 18178776.
      View in: PubMed
    137. Spellberg B. Prospects for and barriers to a fungal vaccine. Expert Opin Biol Ther. 2007 Dec; 7(12):1785-8. PMID: 18034644.
      View in: PubMed
    138. Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE, Spellberg BJ. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest. 2007 Sep; 117(9):2649-57. PMID: 17786247.
      View in: PubMed
    139. Spellberg B, Miller LG, Kuo MN, Bradley J, Scheld WM, Edwards JE. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development. Infection. 2007 Jun; 35(3):167-74. PMID: 17565458.
      View in: PubMed
    140. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007 Jun; 45(4):321-46. PMID: 17510856.
      View in: PubMed
    141. Miller LG, Perdreau-Remington F, Bayer AS, Diep B, Tan N, Bharadwa K, Tsui J, Perlroth J, Shay A, Tagudar G, Ibebuogu U, Spellberg B. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis. 2007 Feb 15; 44(4):471-82. PMID: 17243048.
      View in: PubMed
    142. Spellberg BJ, Collins M, Avanesian V, Gomez M, Edwards JE, Cogle C, Applebaum D, Fu Y, Ibrahim AS. Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. J Leukoc Biol. 2007 Mar; 81(3):632-41. PMID: 17158608.
      View in: PubMed
    143. Reed C, Ibrahim A, Edwards JE, Walot I, Spellberg B. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother. 2006 Nov; 50(11):3968-9. PMID: 17000743.
      View in: PubMed
    144. Spellberg B, Schwartz J, Fu Y, Avanesian V, Adler-Moore J, Edwards JE, Ibrahim AS. Comparison of antifungal treatments for murine fusariosis. J Antimicrob Chemother. 2006 Nov; 58(5):973-9. PMID: 16973654.
      View in: PubMed
    145. Ibrahim AS, Edwards JE, Fu Y, Spellberg B. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother. 2006 Nov; 58(5):1070-3. PMID: 16928702.
      View in: PubMed
    146. Rieg G, Spellberg B, Schwartz J, Fu Y, Edwards JE, Sheppard DC, Ibrahim AS. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2006 Aug; 50(8):2895-6. PMID: 16870798.
      View in: PubMed
    147. Spellberg BJ, Ibrahim AS, Avanesian V, Fu Y, Myers C, Phan QT, Filler SG, Yeaman MR, Edwards JE. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis. J Infect Dis. 2006 Jul 15; 194(2):256-60. PMID: 16779733.
      View in: PubMed
    148. Ibrahim AS, Spellberg BJ, Avanesian V, Fu Y, Edwards JE. The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis. Infect Immun. 2006 May; 74(5):3039-41. PMID: 16622247.
      View in: PubMed
    149. Spellberg B. Immunoglobulin G2 antibodies and HIV-infected long-term nonprogressors: what is the mechanism? J Infect Dis. 2006 Apr 01; 193(7):1047; author reply 1047-8. PMID: 16518769.
      View in: PubMed
    150. Spellberg BJ, Filler SG, Edwards JE. Current treatment strategies for disseminated candidiasis. Clin Infect Dis. 2006 Jan 15; 42(2):244-51. PMID: 16355336.
      View in: PubMed
    151. Spellberg BJ, Ibrahim AS, Avenissian V, Filler SG, Myers CL, Fu Y, Edwards JE. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice. Infect Immun. 2005 Sep; 73(9):6191-3. PMID: 16113347.
      View in: PubMed
    152. Spellberg B, Edwards J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005 Jul; 18(3):556-69. PMID: 16020690.
      View in: PubMed
    153. Spellberg B, Ibrahim AS, Edwards JE, Filler SG. Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis. 2005 Jul 15; 192(2):336-43. PMID: 15962230.
      View in: PubMed
    154. Spellberg B. Carl von Clausewitz (1780-1831) and cholera: the cause of World War II? J Med Biogr. 2005 May; 13(2):108-12. PMID: 19813314.
      View in: PubMed
    155. Spellberg BJ, Collins M, French SW, Edwards JE, Fu Y, Ibrahim AS. A phagocytic cell line markedly improves survival of infected neutropenic mice. J Leukoc Biol. 2005 Aug; 78(2):338-44. PMID: 15857941.
      View in: PubMed
    156. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005 Apr 07; 352(14):1445-53. PMID: 15814880.
      View in: PubMed
    157. Spellberg B. Is computed tomography of the head useful before lumbar puncture? Clin Infect Dis. 2005 Apr 01; 40(7):1061; author reply 1062-3. PMID: 15825004.
      View in: PubMed
    158. Ibrahim AS, Spellberg BJ, Avenissian V, Fu Y, Filler SG, Edwards JE. Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun. 2005 Feb; 73(2):999-1005. PMID: 15664943.
      View in: PubMed
    159. Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JE, Douglas CM. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother. 2005 Feb; 49(2):721-7. PMID: 15673756.
      View in: PubMed
    160. Spellberg B, Fu Y, Edwards JE, Ibrahim AS. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother. 2005 Feb; 49(2):830-2. PMID: 15673781.
      View in: PubMed
    161. Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun. 2005 Feb; 73(2):778-83. PMID: 15664916.
      View in: PubMed
    162. Spellberg B, Yoo T, Bayer AS. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother. 2004 Oct; 54(4):832-5. PMID: 15317746.
      View in: PubMed
    163. Miller LG, Spellberg B. Treatment of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections with drainage but no antibiotic therapy. Pediatr Infect Dis J. 2004 Aug; 23(8):795; author reply 795-6. PMID: 15295240.
      View in: PubMed
    164. Fu Y, Lee H, Collins M, Tsai HF, Spellberg B, Edwards JE, Kwon-Chung KJ, Ibrahim AS. Cloning and functional characterization of the Rhizopus oryzae high affinity iron permease (rFTR1) gene. FEMS Microbiol Lett. 2004 Jun 01; 235(1):169-76. PMID: 15158278.
      View in: PubMed
    165. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004 May 01; 38(9):1279-86. PMID: 15127341.
      View in: PubMed
    166. Spellberg B, Witt MD, Beck CK. Amphotericin B: is a lipid-formulation gold standard feasible? Clin Infect Dis. 2004 Jan 15; 38(2):304-5; author reply 306-7. PMID: 14699470.
      View in: PubMed
    167. Miller LG, Spellberg B. Spider bites and infections caused by community-associated methicillin-resistant Staphylococcus aureus. Surg Infect (Larchmt). 2004; 5(3):321-2; author reply 322. PMID: 15684805.
      View in: PubMed
    168. Spellberg B, Johnston D, Phan QT, Edwards JE, French SW, Ibrahim AS, Filler SG. Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis. Infect Immun. 2003 Oct; 71(10):5756-64. PMID: 14500497.
      View in: PubMed
    169. Ibrahim AS, Avanessian V, Spellberg B, Edwards JE. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob Agents Chemother. 2003 Oct; 47(10):3343-4. PMID: 14506054.
      View in: PubMed
    170. Spellberg B, Rieg G, Bayer A, Edwards JE. Lack of cross-hepatotoxicity between fluconazole and voriconazole. Clin Infect Dis. 2003 Apr 15; 36(8):1091-3. PMID: 12684933.
      View in: PubMed
    171. Spellberg B, Edwards JE. The Pathophysiology and Treatment of Candida Sepsis. Curr Infect Dis Rep. 2002 Oct; 4(5):387-399. PMID: 12228025.
      View in: PubMed